Home LiteratureArticle Details
PMID: 9649424 Published · ppublish English Journal Article

Direct link between cytokine activity and a catalytic site for macrophage migration inhibitory factor.

The EMBO journal ·Vol. 17 ·No. 13 ·1998-07-01 ·Pages 3534-41

Swope M, Sun HW, Blake PR, Lolis E

Abstract

Macrophage migration inhibitory factor (MIF) is a secreted protein that activates macrophages, neutrophils and T cells, and is implicated in sepsis, adult respiratory distress syndrome and rheumatoid arthritis. The mechanism of MIF function, however, is unknown. The three-dimensional structure of MIF is unlike that of any other cytokine, but bears striking resemblance to three microbial enzymes, two of which possess an N-terminal proline that serves as a catalytic base. Human MIF also possesses an N-terminal proline (Pro-1) that is invariant among all known homologues. Multiple sequence alignment of these MIF homologues reveals additional invariant residues that span the entire polypeptide but are in close proximity to the N-terminal proline in the folded protein. We find that p-hydroxyphenylpyruvate, a catalytic substrate of MIF, binds to the N-terminal region and interacts with Pro-1. Mutation of Pro-1 to a glycine substantially reduces the catalytic and cytokine activity of MIF. We suggest that the underlying biological activity of MIF may be based on an enzymatic reaction. The identification of the active site should facilitate the development of structure-based inhibitors.

MeSH Terms
Amino Acid Sequence Animals Binding Sites Catalysis Humans Macrophage Migration-Inhibitory Factors/chemistry,genetics,immunology,metabolism Models, Molecular Molecular Sequence Data Neutrophils/immunology Phenylpyruvic Acids/metabolism Protein Conformation Recombinant Fusion Proteins Sequence Analysis Sequence Homology, Amino Acid Substrate Specificity
Chemicals
Macrophage Migration-Inhibitory Factors Phenylpyruvic Acids Recombinant Fusion Proteins 4-hydroxyphenylpyruvic acid
Authors & Affiliations
4 authors, click to expand affiliations / ORCID
Swope M
Department of Pharmacology, Yale University School of Medicine, 333 Cedar Street, New Haven, CT 06510, USA.
Sun H W
Blake P R
Lolis E
References (32)
32 references, click to expand
  1. Interleukin-1 receptor antibody (IL-1rab) protection and treatment against lethal endotoxemia in mice.
    J Surg Res. 1993 Apr;54(4):316-21 PMID: 8331925
  2. The macrophage migration inhibitory factor MIF is a phenylpyruvate tautomerase.
    FEBS Lett. 1997 Nov 3;417(1):85-8 PMID: 9395080
  3. Mechanism of a reaction in vitro associated with delayed-type hypersensitivity.
    Science. 1966 Jul 1;153(3731):80-2 PMID: 5938421
  4. Delayed hypersensitivity in vitro: its mediation by cell-free substances formed by lymphoid cell-antigen interaction.
    Proc Natl Acad Sci U S A. 1966 Jul;56(1):72-7 PMID: 5229858
  5. A comprehensive set of sequence analysis programs for the VAX.
    Nucleic Acids Res. 1984 Jan 11;12(1 Pt 1):387-95 PMID: 6546423
  6. Priming of neutrophils for enhanced release of oxygen metabolites by bacterial lipopolysaccharide. Evidence for increased activity of the superoxide-producing enzyme.
    J Exp Med. 1984 Dec 1;160(6):1656-71 PMID: 6096475
  7. Shock and tissue injury induced by recombinant human cachectin.
    Science. 1986 Oct 24;234(4775):470-4 PMID: 3764421
  8. Anti-cachectin/TNF monoclonal antibodies prevent septic shock during lethal bacteraemia.
    Nature. 1987 Dec 17-23;330(6149):662-4 PMID: 3317066
  9. Interleukin 1 induces a shock-like state in rabbits. Synergism with tumor necrosis factor and the effect of cyclooxygenase inhibition.
    J Clin Invest. 1988 Apr;81(4):1162-72 PMID: 3258319
  10. The neurotrophic factor neuroleukin is 90% homologous with phosphohexose isomerase.
    Nature. 1988 Mar 31;332(6163):454-5 PMID: 3352744
  11. Domains specifying thrombin-receptor interaction.
    Nature. 1991 Oct 17;353(6345):674-7 PMID: 1717851
  12. Identification of cyclophilin as a proinflammatory secretory product of lipopolysaccharide-activated macrophages.
    Proc Natl Acad Sci U S A. 1992 Apr 15;89(8):3511-5 PMID: 1565646
  13. Leukocyte chemotactic activity of cyclophilin.
    J Biol Chem. 1992 Jun 15;267(17):11968-71 PMID: 1601866
  14. Leukocyte chemotactic activity of FKBP and inhibition by FK506.
    Biochem Biophys Res Commun. 1992 Jul 31;186(2):1178-83 PMID: 1379802
  15. Purification of macrophage migration inhibitory factor (MIF) from bovine brain cytosol.
    FEBS Lett. 1993 Mar 22;319(3):233-6 PMID: 8458415
  16. MIF is a pituitary-derived cytokine that potentiates lethal endotoxaemia.
    Nature. 1993 Oct 21;365(6448):756-9 PMID: 8413654
  17. Molecular cloning and functional expression of a cDNA encoding glycosylation-inhibiting factor.
    Proc Natl Acad Sci U S A. 1993 Nov 1;90(21):10056-60 PMID: 8234256
  18. The monofunctional chorismate mutase from Bacillus subtilis. Structure determination of chorismate mutase and its complexes with a transition state analog and prephenate, and implications for the mechanism of the enzymatic reaction.
    J Mol Biol. 1994 Jul 29;240(5):476-500 PMID: 8046752
  19. Purification, bioactivity, and secondary structure analysis of mouse and human macrophage migration inhibitory factor (MIF).
    Biochemistry. 1994 Nov 29;33(47):14144-55 PMID: 7947826
  20. CXC chemokines connective tissue activating peptide-III and neutrophil activating peptide-2 are heparin/heparan sulfate-degrading enzymes.
    J Biol Chem. 1995 Feb 17;270(7):3268-77 PMID: 7852412
  21. MIF as a glucocorticoid-induced modulator of cytokine production.
    Nature. 1995 Sep 7;377(6544):68-71 PMID: 7659164
  22. An essential role for macrophage migration inhibitory factor in the tuberculin delayed-type hypersensitivity reaction.
    J Exp Med. 1996 Jan 1;183(1):277-82 PMID: 8551232
  23. Enzymatic ketonization of 2-hydroxymuconate: specificity and mechanism investigated by the crystal structures of two isomerases.
    Biochemistry. 1996 Jan 23;35(3):792-802 PMID: 8547259
  24. 4-Oxalocrotonate tautomerase: pH dependence of catalysis and pKa values of active site residues.
    Biochemistry. 1996 Jan 23;35(3):814-23 PMID: 8547261
  25. The crystal structure of human glycosylation-inhibiting factor is a trimeric barrel with three 6-stranded beta-sheets.
    Proc Natl Acad Sci U S A. 1996 Apr 2;93(7):3007-10 PMID: 8610159
  26. Crystal structure of the macrophage migration inhibitory factor from rat liver.
    Nat Struct Biol. 1996 Mar;3(3):259-66 PMID: 8605628
  27. Crystal structure at 2.6-A resolution of human macrophage migration inhibitory factor.
    Proc Natl Acad Sci U S A. 1996 May 28;93(11):5191-6 PMID: 8643551
  28. An essential regulatory role for macrophage migration inhibitory factor in T-cell activation.
    Proc Natl Acad Sci U S A. 1996 Jul 23;93(15):7849-54 PMID: 8755565
  29. The subunit structure of human macrophage migration inhibitory factor: evidence for a trimer.
    Protein Eng. 1996 Aug;9(8):631-5 PMID: 8875640
  30. NMR characterization of structure, backbone dynamics, and glutathione binding of the human macrophage migration inhibitory factor (MIF).
    Protein Sci. 1996 Oct;5(10):2095-103 PMID: 8897610
  31. The immunoregulatory mediator macrophage migration inhibitory factor (MIF) catalyzes a tautomerization reaction.
    Mol Med. 1996 Jan;2(1):143-9 PMID: 8900542
  32. Direct association of adenosine deaminase with a T cell activation antigen, CD26.
    Science. 1993 Jul 23;261(5120):466-9 PMID: 8101391
Article Info
Journal
The EMBO journal
Abbr.
EMBO J
ISSN
0261-4189
Published
1998-07-01
Pages
3534-41
Language
English
Region
England
NLM ID
8208664
PMCID
PMC1170690
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]